1. Home
  2. CNTB vs LEE Comparison

CNTB vs LEE Comparison

Compare CNTB & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • LEE
  • Stock Information
  • Founded
  • CNTB 2012
  • LEE 1890
  • Country
  • CNTB United States
  • LEE United States
  • Employees
  • CNTB N/A
  • LEE N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • CNTB Health Care
  • LEE Consumer Discretionary
  • Exchange
  • CNTB Nasdaq
  • LEE Nasdaq
  • Market Cap
  • CNTB 54.4M
  • LEE 39.6M
  • IPO Year
  • CNTB 2021
  • LEE N/A
  • Fundamental
  • Price
  • CNTB $1.41
  • LEE $6.96
  • Analyst Decision
  • CNTB Strong Buy
  • LEE
  • Analyst Count
  • CNTB 2
  • LEE 0
  • Target Price
  • CNTB $7.50
  • LEE N/A
  • AVG Volume (30 Days)
  • CNTB 156.2K
  • LEE 34.0K
  • Earning Date
  • CNTB 09-04-2025
  • LEE 07-31-2025
  • Dividend Yield
  • CNTB N/A
  • LEE N/A
  • EPS Growth
  • CNTB N/A
  • LEE N/A
  • EPS
  • CNTB N/A
  • LEE N/A
  • Revenue
  • CNTB $26,033,000.00
  • LEE $591,094,000.00
  • Revenue This Year
  • CNTB N/A
  • LEE N/A
  • Revenue Next Year
  • CNTB N/A
  • LEE N/A
  • P/E Ratio
  • CNTB N/A
  • LEE N/A
  • Revenue Growth
  • CNTB N/A
  • LEE N/A
  • 52 Week Low
  • CNTB $0.51
  • LEE $5.83
  • 52 Week High
  • CNTB $1.60
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 66.20
  • LEE 60.74
  • Support Level
  • CNTB $1.05
  • LEE $6.04
  • Resistance Level
  • CNTB $1.20
  • LEE $7.00
  • Average True Range (ATR)
  • CNTB 0.09
  • LEE 0.38
  • MACD
  • CNTB 0.01
  • LEE 0.11
  • Stochastic Oscillator
  • CNTB 82.76
  • LEE 100.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: